Question

What will be the vaccine efficacy of the two-dose Johnson & Johnson Ad26.COV2.S vaccine candidate according to the results of Phase III testing?

Total Forecasters32

Community Prediction89.8 (82.6 - 94.5)

Make a Prediction

PDF

CDF

This question is closed for predictions, and is waiting to be resolved

	lower 25%	median	upper 75%
community	82.61	89.82	94.5
My Prediction	—	—	—

Quartiles	community	My Prediction
lower 25%	82.61	—
median	89.82	—
upper 75%	94.5	—

Authors:

juancambeiro

Opened:

Mar 12, 2021

Closed:

Oct 4, 2021

Scheduled resolution:

Feb 1, 2026

Phases of clinical research

Epidemiology

SK Bioscience approved for Japanese encephalitis vaccine trial in Australia

Korea Herald•Feb 19, 2025

mRNA vaccines show promise in pancreatic cancer in early trial

NBC•Feb 19, 2025

Yale scientists link Covid vaccines to alarming new syndrome causing 'distinct biological changes' to body

Daily Mail•Feb 20, 2025

Learn more about Metaculus NewsMatch

Will the cancer pill AOH1996 enter Phase III clinical trials before January 1, 2027?

24.2%

When will an intranasal SARS-CoV-2 vaccine be approved by the US?

2025-10-22

What will be the COVID-19 booster coverage for the 2024-25 season among the following groups in the US?

48.1

Comments

? comments